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Abstract Genetic information regarding the leader
(L) and complete capsid-coding (P1) region of FMD
serotype A and O viruses prevalent on the African conti-
nent is lacking. Here, we present the complete L-P1
sequences for eight serotype A and nine serotype O viruses
recovered from FMDV outbreaks in East and West Africa
over the last 33 years. Phylogenetic analysis of the P1 and
capsid-coding regions revealed that the African isolates
grouped according to serotype, and certain clusters were
indicative of transboundary as well as intra-regional spread
of the virus. However, similar analysis of the L region
revealed random groupings of isolates from serotypes O
and A. Comparisons between the phylogenetic trees
derived from the structural coding regions and the L region
pointed to a possibility of genetic recombination. The in-
tertypic nucleotide and amino acid variation of all the
isolates in this study supported results from previous
studies where the externally located 1D was the most
variable whilst the internally located 1A was the most
conserved, which likely reflects the selective pressures on
these proteins. Amino acids identified previously as
important for FMDV structure and functioning were found
to be highly conserved. The information gained from this
study will contribute to the construction of structurally
designed FMDV vaccines in Africa.
Introduction
Foot-and-mouth disease (FMD) is a highly contagious
disease that affects domestic and wild cloven-hoofed ani-
mals [2, 77]. Despite all the information accumulated over
the years on many aspects of FMD basic biology, there is
still a lack of information regarding FMD virus transmis-
sion, maintenance, virulence and host range. Although
FMD is referred to as a single disease [18], the causative
agent of the disease, FMD virus (FMDV), consists of seven
immunologically distinct serotypes [23, 24]. The FMDV
serotypes, i.e., A, O, C, Asia 1 and the South African
Territories (SAT) types 1, 2 and 3, have different global
geographical distribution patterns [8–10, 18, 44, 73, 88]
and are endemic in many countries. Even on the African
continent, the distribution of serotypes is variable, with the
SAT serotypes occurring in most regions of sub-Saharan
Africa but A and O confined mostly to the central and
northern parts of the region [88]. Mortality is usually low,
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but morbidity can reach 100 % and therefore remains a
major economic concern for livestock health in many
developing countries and a continued threat to disease-free
countries [44]. The eradication and control of FMDV in
Africa is complex and difficult due to the role of wildlife in
virus spread and maintenance [82] and the presence of six
of the seven serotypes, i.e., A, O, C, SAT1, SAT2 and
SAT3. Serotype C has not been reported since 2004 [22].
FMDV is a non-enveloped virus containing a single-
stranded RNA genome of positive polarity in the genus
Aphthovirus of the family Picornaviridae [1, 2, 27]. The
large open reading frame (ORF) of *6,996 nt, which
differs in length between the different serotypes [20],
encodes a single polypeptide, which is co- and posttransl-
ationally cleaved by viral proteases to give rise to the
structural and non-structural proteins [3, 13, 55, 67]. Ten of
the 13 cleavage events are catalysed by the virally encoded
3C protease [15, 58, 67, 78]. Translation takes place from a
single open reading frame by a cap-independent mecha-
nism at the internal ribosome entry site (IRES) [49],
located in the 5’ untranslated region (UTR). There are two
different sites on the RNA at which the initiation of protein
synthesis occurs, resulting in the generation of two forms
of L proteinase (Lpro), Lb and the less abundant Lab, where
Lb is the truncated version, which arises after the initiation
of translation at the second AUG start codon [13]. Lab and
Lb can cleave the L/P1 junction and ensure the proteolytic
degradation of the cellular cap-binding protein complex
(eIF4G), which results in the shutoff of host translation
[22]. The P1 region is the viral capsid precursor and con-
sists of the proteins 1A (VP4), 1B (VP2), 1C (VP3) and 1D
(VP1). The antigenicity of the viral particles is dependent
on the amino acid (aa) residues that are exposed on the
surface of the capsid [56, 85]. Furthermore, it has been
shown that the external capsid proteins play a role in
binding to the FMDV cell-surface receptors, i.e., the RGD-
dependant integrins [14, 25, 37–39, 59, 60] and heparan
sulphate proteoglycans (HSPGs) [4, 36, 68].
The genetic heterogeneity of the virus, which is due to
the lack of a proofreading mechanism during virus repli-
cation, has resulted in the occurrence of extensive vari-
ability as well as different lineages and antigenic variants
within a serotype that have established themselves in dif-
ferent geographical regions [reviewed in refs. 8–10, 44, 70,
71, 75, 76, 88]. This has resulted in the need for multiple
vaccine strains required for each serotype to cover the
antigenic diversity when using vaccination as a control
option [26]. In Africa and countries bordering Europe, the
disease is mainly controlled using vaccination and restric-
tion of animal movement. Thus, it is imperative to obtain
as much information as possible regarding the FMDV
prevalent on the African continent to further our knowl-
edge on FMD epidemiology, define genetic relationships of
viruses causing outbreaks [45, 47] and to enable better
control strategies by successful vaccine development.
Genetic information regarding the leader (L) and com-
plete capsid-coding (P1) region of serotype A and O
viruses prevalent on the African continent is lacking,
although the SAT isolates have been broadly studied in the
past [8–10, 86]. For this study, the L and P1 coding regions
for eight FMDV A and nine FMDV O viruses isolated
between 1975 and 2003 were successfully sequenced and
analysed using phylogenetic analysis, examination of
sequence variability, and identification of highly conserved
genomic regions relating to previously identified FMDV
functional and structural biological capabilities. Non-con-
servative substitutions were mapped to the available O
(O1BFS) [53] and A (A10/HOL/61) [29] capsid structures,
and amino acid substitutions that may be involved in
antigenic divergence were identified.
Materials and methods
Viruses included in this study
The sub-Saharan African isolates included in this study
belong to different topotypes of FMDV serotypes A and O
as defined by 1D sequencing and represent a broad geo-
graphical distribution of viruses within East and West
Africa. The nine FMDV serotype O isolates and eight
serotype A isolates were obtained from the Institute for
Animal Health, Pirbright Laboratory, Pirbright, United
Kingdom (Table 1). For the purpose of analysis, a select
few complete L and P1 FMDV sequences currently avail-
able in GenBank were included (Table 1).
Cell culture propagation of viruses
The FMDV type O viruses were passaged for a previous
study and were used directly in this study for processing,
whereas the FMDV A isolates were first propagated on IB-
RS-2 cells (Instituto Biologico renal suino cell line, a pig
kidney cell line) to obtain a high viral titer. The IB-RS-2
cells were maintained in RPMI medium (Sigma) supple-
mented with 10 % foetal calf serum (FCS; Delta Bio-
products) and 1x Antibiotic-Antimycotic (1009, Gibco),
Invitrogen). Virus was added to prepared cells containing
RPMI supplemented with 1 % (v/v) FCS and 19 Antibi-
otic-Antimycotic mixture and incubated at 37 C until
complete CPE was attained (after 48 h). Clarified cell
culture supernatant containing virus was stored at -80 C
until further use.
Chinese hamster ovary (CHO) cells strain K1 (ATCC
CCL-61) were maintained in Ham’s F-12 medium (Invit-
rogen) supplemented with 10 % FCS. Plaque assays were
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Table 1 Description of viruses used for genetic analysis of the coding sequences of the L and capsid proteins
Virus straina,d Country of origin References GenBank
accession no.
Passage historyb Topotypesc
O/ETH/3/96* Ethiopia This study EU919240 RS2 East Africa (EA)
O/UGA/5/96* Uganda This study EU919247 RS2 East Africa (EA)
O/KEN/10/95* Kenya This study EU919242 RS3 East Africa (EA)
O/SUD/4/80* Sudan This study EU919239 RS2 East Africa (EA)
O/UGA/17/98*,m Uganda This study EU919245 RS2 East Africa (EA)
O/UGA/1/75*,m Uganda This study EU919244 RS2 East Africa (EA)
O/UGA/6/76*,m Uganda This study EU919246 RS2 East Africa (EA)
O/TAN/3/96* Tanzania This study EU919241 RS2 East Africa (EA)
O/UGA/7/03* Uganda This study EU919243 PK1 RS1 East Africa (EA)
O/UKG/35/2001 United Kingdom Carrillo et al. [29] AJ539141 - Middle East-South Asia (ME-SA)
OFRA/1/2001 France Nobiron et al. [61] AJ633821 - Middle East-South Asia (ME-SA)
O/SAR/19/2000 South Africa Carrillo et al. [29] AJ539140 - Middle East-South Asia (ME-SA)
O/TAW/2/99 Taiwan Carrillo et al. [29] AJ539137 - Middle East-South Asia (ME-SA)
O/TIBET/CHA/99 China Carrillo et al. [29] AJ539138 - Middle East-South Asia (ME-SA)
O/CHINA/1/99 China Zhang et al. [89] AF506822 - Middle East-South Asia (ME-SA)
O/SKR/2000 South Korea Carrillo et al. [29] AJ539139 - Middle East-South Asia (ME-SA)
O/O10PHIL76 Philippines Carrillo et al. [29] AY593812 - South East Asia (SEA)
O/O10PHIL54 Philippines Carrillo et al. [29] AY593811 - South East Asia (SEA)
O/O1MANISA87 Turkey Carrillo et al. [29] AY593823 - Middle East-South Asia (ME-SA)
O/AKESU/58 China Li et al. [52] AF511039 - Middle East-South Asia (ME-SA)
O/11INDONESIA52 Indonesia Carrillo et al. [29] AY593813 - South-East Asia
O/O1BRUGGE79 Belgium Carrillo et al. [29] AY593817 - Europe-South America (Euro-SA)
O/O1ARGENTINA65 Argentina Carrillo et al. [29] AY593814 - Europe-South America (Euro-SA)
O/O1CAMPOS94 Argentina Carrillo et al. [29] AY593819 - Europe-South America (Euro-SA)
O/O1CAMPOS96 Brazil Carrillo et al. [29] AY593818 - Europe-South America (Euro-SA)
O/O1BFS46 United Kingdom Carrillo et al. [29] AY593816 - Europe-South America (Euro-SA)
O/O1BFS18 United Kingdom Carrillo et al. [29] AY593815 - Europe-South America (Euro-SA)
A/CIV/4/95*,m Cote d’Ivoire This study EU919236 BTY1 RS2 Africa
A/ERI/3/98*,m Eritrea This study EU919238 BTY1 RS2 Africa
A/ETH/2/79* Ethiopia This study EU919233 BTY5 RS2 Africa
A/ETH/7/92*,m Ethiopia This study EU919235 BTY1 RS2 Africa
A/NIG/4/79*,m Nigeria This study EU919234 BTY2 BHK4 RS2 Africa
A/SEN/10/97*,m Senegal This study EU919237 BTY2 RS2 Africa
A/SOM/1/78* Somalia This study EU919231 BTY2 RS2 Africa
A/TAN/4/80* Tanzania This study EU919232 BTY2 RS2 Africa
A/A18ZULIA40 Venezuela Carrillo et al. [29] AY593758 - Europe-South America (Euro-SA)
A/A1BRAZIL75 Brazil Carrillo et al. [29] AY593753 - Europe-South America (Euro-SA)
A/A17AGUARULBOS83 Brazil Carrillo et al. [29] AY593757 - Europe-South America (Euro-SA)
A/APHILIPPINES50 Philippines Carrillo et al. [29] AY593793 - Asia
A/A29PERU37 Peru Carrillo et al. [29] AY593773 - Europe-South America (Euro-SA)
A/BRAZIL67 Brazil Carrillo et al. [29] AY593788 - Europe-South America (Euro-SA)
A/A24CRUZEIRO71 Brazil Carrillo et al. [29] AY593768 - Europe-South America (Euro-SA)
A/A4SPAIN62 Spain Carrillo et al. [29] AY593778 - Europe-South America (Euro-SA)
A/A14SPAIN39 Spain Carrillo et al. [29] AY593754 - Europe-South America (Euro-SA)
A/A5WESTERWALD73 West Germany Carrillo et al. [29] AY593781 - Europe-South America (Euro-SA)
A/A5ALLIER45 France Carrillo et al. [29] AY593780 - Europe-South America (Euro-SA)
A/A12VALLE119/20 Great Britain Carrillo et al. [29] AY593752 - Europe-South America (Euro-SA)
A/A10HOLLAND82 Holland Carrillo et al. [29] AY593751 - Europe-South America (Euro-SA)
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performed by infecting monolayer cells with the virus for 1
h, followed by the addition of a 2-ml tragacanth overlay
[66] and staining with 1 % (w/v) methylene blue [54].
RNA extraction, RT-PCR and sequencing
Total viral RNA was extracted using a modified guanidi-
nium thiocyanate (GuSCN)-silica method [17]. The viral
RNA template was reverse transcribed at 42 C for 1 h
using 10 U of AMV reverse transcriptase (Promega) and
the antisense P1 primer (WDA; 5’-GAAGGGCCCAGGG
TTGGACTC-3’) [12] as described previously [7]. Ampli-
fication of the L-P1 region was undertaken using the
antisense P1 (WDA) primer and the sense NCR1 primer
(5’-TACCAAGCGACACTCGGGATCT-3’) followed by
PCR reactions using long-template Taq DNA polymerase
(Roche) and thermal cycling conditions described by van
Rensburg et al. [86].
PCR products of ca. 2,820 bp were excised from a 1 %
agarose gel and purified using a Nucleospin Extract Kit
(Macherey-Nagel). Purified PCR products were sequenced
using a genome-walking approach with genome-specific
oligonucleotides and an ABI PRISMTM BigDye Termi-
nator Cycle Ready Reaction Kit v3.1 (Applied Biosys-
tems). Sequences were analysed using an ABI Prism 3100
Genetic Analyser (Applied Biosystems).
Data analysis
Ambiguous nucleotides (nt) of the L-P1 sequences were
resolved manually and assembled into a contig using the
SEQUENCHERTM 4.7 DNA sequence analysis software
(Gene Codes Corporation, Ann Arbor, MI, USA). A con-
sensus sequence representing the most probable nt for each
position of the sequence was obtained for each isolate.
Consensus sequences were translated in BioEdit 5.0.9
DNA sequence analysis software [32], and the complete
L-P1 nt and aa sequences were aligned using ClustalX
1.8.1 [83]. Hypervariable regions in the complete aa
alignment were defined as a linear 10-aa region containing
more than 50 % variable residues. The phylogenetic ana-
lysis included the newly determined sequences as well as
sequences of non-African serotype A and O isolates
obtained from GenBank (Table 1). Maximum-likelihood
analysis of the aligned sequences was carried out in PAUP
[79] under the Aikake Information Criterion. Phylogenetic
trees were constructed using the neighbour-joining (NJ),
minimum-evolution (ME) and maximum-parsimony (MP)
methods included in the MEGA 4.0 program [50] for the L,
1A, 1B, 1C, 1D-coding regions separately as well as the
full P1-coding region. Node reliability was estimated by
1000 bootstrap replications for NJ, ME and MP trees,
whilst the nucleotide substitution model of Kimura
2-parameter was employed for the NJ and ME trees and
close-neighbour-interchange (CNI) with search level 1 in
effect for the MP and ME trees. MEGA 4.0 [50] was uti-
lised to determine the nt and aa variation.
Plots representing the aa variation, hydrophobicity and
secondary structures for each protein were drawn using
Python (http://python.org) and the matplotlib package (http://
matplotlib.sourceforge.net). The number of different amino
acids occurring at a specific position was used as a measure of
variation, and the hydrophobicity scale of Kyte and Doolittle
[51] was used to measure relative aa hydrophobicity.
The crystallographic protomers of the capsid proteins of
O1BFS (1FOD) [53] and A10/HOL/61 ((1ZBE) [29] were
visualized and the surface-exposed residues identified with
PyMol v1.1rc2pre (DeLano Scientific LLC).
Table 1 continued
Virus straina,d Country of origin References GenBank
accession no.
Passage historyb Topotypesc
A/A1BAYERN41 Germany Carrillo et al. [29] AY593759 - Europe-South America (Euro-SA)
A/A3MECKLENBURG81 Germany Carrillo et al. [29] AY593776 - Europe-South America (Euro-SA)
A/A2SPAIN7 Spain Carrillo et al. [29] AY593774 - Europe-South America (Euro-SA)
A/A4WGERMANY72 West Germany Carrillo et al. [29] AY593779 - Europe-South America (Euro-SA)
A/A4WGERMANY42 West Germany Carrillo et al. [29] AY593777 - Europe-South America (Euro-SA)
a The viruses labeled ‘‘*’’ represent isolates from Africa
b RS is the number of passages on IB-RS-2 (Instituto Biologico renal suino) porcine kidney cells; BTY, on primary bovine thyroid cells; PK, on
primary porcine kidney cells; and BHK, on baby hamster kidney cells. The number following the cell line indicates the number of times a virus
was passaged in that particular cell line. (-) information is not available
c The topotypes are as described by Knowles and Samuel [18]
d The viruses labeled ‘‘m’’ represent the African O isolates that have a codon insertion between nt 77 and 79 and the African A isolates that have
a codon insertion or deletion between nt 54 and 61
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Results
Phylogenetic relationships and genetic heterogeneity
of the serotype A and O isolates in Africa
Phylogenetic trees based on the P1 (Fig. 1), 1B, 1C and
1D regions that included all of the A and O isolates used
in this study (Table 1) revealed groupings strictly
according to serotype, irrespective of the phylogenetic
methodology applied. In general, analysis of the entire
structural protein-coding region improved bootstrap
values compared to 1D analysis alone. Phylogenetic
clusters of the A and O isolates were described using the
names published previously by Knowles and Samuel [44]
(Table 1).
The P1 phylogeny for serotypes O viruses revealed that
the African isolates clustered separately from the Pan-
Asian O and non-African O isolates (Fig. 1), the latter
belonging to the Middle East-South Asia (ME-SA) topo-
type based on 1D phylogeny [44]. The exception is O/SAR/
19/2000, which was isolated in South Africa in 2000 during
an outbreak caused by illegal feeding of swill to pigs [74].
•
*
Pan Asian FMDV O
African FMDV A and O types (this study)
Non-African FMDV A and O types



































































































































Fig. 1 Neighbour-joining tree
depicting genetic relationships
for the P1 region of FMDV A
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This outbreak was controlled, and the virus no longer exists
in southern Africa.
For the African isolates, significant bootstrap support
was obtained for a group consisting of O/TAN/3/96 and
O/UGA/7/03 (East African; EA-2) as well as for a group
with O/KEN/10/95 and O/UGA/5/96 (East African; EA-1)
and lastly for O/SUD/4/80, O/UGA/1/75, O/UGA/17/98
and O/UGA/6/76 (East African; EA-4) (Fig. 1). Further-
more, these P1 groupings were also observed when ME and
MP phylogenetic models were utilised (not shown).
Clustering similar to that of the P1 region was observed
for the separate gene regions, but with low bootstrap sup-
port except for 1B (O/UGA/7/03 and O/TAN/3/93,
O/UGA/6/76 and O/UGA/17/98), 1C (O/UGA/17/98 and
O/UGA/6/76) and 1D (OKEN/10/95 and O/UGA/5/96)
groupings, which had high bootstrap support (Supplemen-
tary data, S1-S3). O/ETH/3/96 is the only representative of
the EA-3 topotype in this study; thus, it did not cluster with
the other isolates (Fig. 1). The nt sequence differences in
the P1-coding region between members of each topotype
were typically more than 15 %, similar to the cutoff
defined for a topotype [47].
Globally, FMDV serotype A exists in three geographi-
cally distinct topotypes, Asia, Africa and Europe-South
America (Euro-SA), based on the genetic relationships of
1D sequences [44]. Using the sequence information of the
African A isolates together with P1 sequences of serotype
A viruses available in the GenBank database, at least two
separate clusters were observed for the type A viruses, i.e.,
non-African and African A isolates, supported by 100 %
bootstrap values for all phylogenetic methods used for the
P1 (Fig. 1), 1B, 1C and 1D gene regions (Supplementary
data, S1-S3). Two East African isolates, A/TAN/4/80 and
A/SOM/1/78 formed a well-supported subgroup for the P1
(Fig. 1) and 1D NJ trees (Supplementary data, S3). In
addition, there was a consistently strong grouping for three
West African isolates, A/NIG/4/79, A/CIV/4/95 and
A/SEN/1/97, in the P1 (Fig. 1), 1B, 1C and 1D NJ analyses
(Supplementary data, S1-S3).
The serotype A non-African and African viruses dis-
played similar genetic variability when compared to sero-
type O. The intratypic nt sequence variation in an
alignment of the 2222-nt P1-coding region for type A was
calculated to be 40.4 %, whilst the corresponding region
(2202-2205 nt) of type O only revealed 38.5 % variable
nucleotides.
Analysis of the 1A gene region resulted in phylogenetic
groupings that differed from those of the P1, 1B, 1C and
1D analyses. When performing phylogenetic analysis on
the combined O and A dataset, the FMDV A and O isolates
did not group strictly according to serotype (Supplemen-
tary data, S4). For example, three non-African FMDV A
strains, isolated from Brazil and Venezuela (A17/AGUA-
RULBOS/ISO83, A18/ZULIA/ISO48 and A13/BRAZIL/
ISO75), grouped with O viruses from the ME-SA, SEA and
EA topotypes, but with low bootstrap support. As expected,
the region encoding 1A was the most conserved, exhibiting
37.9 % variant nucleotides and was the only capsid-coding
region with the highest average %Ts/Tv rate of 1.0 %
(Table 2). In contrast, 1D had the highest variability of
58.7 % and lowest average %Ts/Tv rate of 0.28 %
(Table 2).
The phylogenetic trees based on the Lpro-coding region
for the combined serotype O and A dataset had similar tree
topologies for the A and O isolates, independent of the
phylogenetic methods employed. The NJ tree of the Lpro-
coding region (Fig. 2) showed that the viruses did not
group strictly according to serotype, in contrast to those
Table 2 Variation within the nucleotide and amino acid sequences of the L and P1 polyprotein in a complete alignment of the non-African and
African A and O sequences
Genome
region
No. of nt positions
aligneda






% of variant aab
All A O All A O All All A O All A O
L 618 318 274 267 51.5 44.3 43.0 0.470 206 111 96 61 53.9 46.6 29.6
1A 256 97 94 76 37.9 36.7 29.7 1.045 85 13 13 4 15.3 15.3 4.7
1B 657 309 253 227 47.0 38.5 34.6 0.314 218 72 53 25 33.0 24.3 11.5
1C 667 318 254 275 47.7 38.1 41.2 0.345 222 89 63 36 40.1 28.4 16.2
1D 642 377 293 277 58.7 45.6 43.0 0.283 214 116 92 64 54.2 43.0 29.9
P1 2222 1162 894 855 52.3 40.4 38.5 0.104 739 296 224 128 40.1 30.3 17.2
a The number of nucleotides and amino acids were based on Clustal X alignments of the complete P1-coding region of the A and O serotypes
b The number of variant nucleotides or amino acids for each genomic region or capsid protein relative to the total number of positions was used
to estimate the percentage (%) variability
Fig. 2 Neighbour-joining tree depicting genetic relationships for the
L region of FMDV A and O type viruses. The Kimura 2-parameter
model and bootstrap analysis (1000 replications) were applied
c




































































































• Pan Asian FMDV O
African FMDV A and O types 
(this study)
( ) Bootstrap value from minimum
evolution tree














(E) (F) Variation in 1C-AVariation in 1C-O
Variation in 1B-AVariation in 1B-O
Variation in 1D-O Variation in 1D-A
Fig. 3 Plots representing the aa variation and hydrophobicity for 1D
(a, b), 1B (c, d) and 1C (e, d) for the African type A (b, d, f) and O (a,
c, e) viruses from this study. The pink bars represent the beta strands
of the FMDV structure, whilst the yellow represent the alpha helices.
Areas of FMDV hydrophobicity and aa variation are represented by
blue and green lines, respectively. Regions of variability or hyper-
variable sites were defined as sites on the P1 that had five or more
variable aa residues within a window of 10 residues
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based on the structural proteins. The non-African A and O
isolates that form a part of the Euro-SA lineage [44]
formed separate subgroupings in the Lpro-coding sequence
NJ tree (Fig. 2). The Pan-Asian isolates formed a separate
grouping with high bootstrap support (100 %). The five
non-African O isolates that do not form a part of the Euro-
SA lineage (isolates from the Philippines, Indonesia and
China as well as the vaccine strain O1 Manisa originally
isolated in Turkey; Table 1) grouped within the cluster of
the African isolates, but as separate groupings. The
majority of the African A and O viruses were found within
two separate clusters, i.e., one containing western Africa
type A isolates and the other, eastern Africa type O and A
(Fig. 2). Interestingly, one West African isolate, A/NIG/4/
79, grouped with significantly high support with A/ETH2/
79, an East African isolate. Also, a similarly strong
grouping was observed for one East African (A/ERI/3/98)
and two West African viruses (A/SEN/10/97 and A/CIV/4/
95) (Fig. 2). There were also close relationships between
African O and A viruses (O/ETH/3/96 and A/SOM/1/789;
O/SUD/4/80 and A/TAN/4/80; O/UGA/6/76 and A/ETH/7/
92), but these were not supported by high bootstrap values.
The nt variation for the Lpro-coding sequence was 51.5 %
compared to 52.3 % for the P1 region (Table 2). The variation
in the Lpro-coding sequence of the African isolates was further
highlighted by a codon insertion between nt 77 and 79 for the
Ugandan isolates O/UGA/17/98, O/UGA/1/75 and O/UGA/6/
76 as well as by a codon insertion or deletion in A/CIV/4/95,
A/ERI/3/98, A/ETH/2/79, A/ETH/7/92, A/NIG/4/79 and
A/SEN/10/97 between nt 54 and 61 (Table 1).
Distribution of aa variation and hypervariability
of the L and P1 polypeptides
The Lpro aa sequence displayed significant variation for a
functional protein: 46.6 % for the serotype A alignment
and 29.6 % for the serotype O isolates (Table 2). At least
30.3 % (224 of 739 aa) of the aa residues were variable in
the alignment of the structural proteins (translated from the
P1 region) of the 26 serotype A isolates, whilst the
Table 3 Amino acid variation at amino acid position 56 of 1C and
the relative infectivity of African O viruses in CHO-K1 cells







O/UGA/5/96 His - -
O/SUD/4/80 His - -
O/ETH/3/96 His - -
O/TAN/3/96 His - -
O/KEN/10/95 Arg 3.63 9 104 \2
O/UGA/7/03 His - -
O/UGA/1/75 His - -
O/UGA/17/98 His - -
O/UGA/6/76 His - -
a His=histidine; Arg=arginine




















Fig. 4 The location of surface-exposed amino acid differences in the
capsid proteins of African serotype A (A) and O (B) viruses on the
crystallographic protomers of O1BFS (1FOD; Logan et al. [53]) and
A10/61 (1QQP; Fry et al. [28]). The protein subunits are colour-coded:
1D (teal), 1B (green), 1C (magenta) and the G-H loop of 1D (red).
The G-H loop of A10/61 (residues 138-158) is not resolved in the
available structure and is not indicated here (A). The hypervariable
amino acid positions in the G-H loop of O1BFS are shown in orange
(B). 1A has been hidden from the structure. The fivefold and threefold
axes of the capsid are indicated. The positions of surface-exposed
residues with high variability are indicated in yellow. The surface
view was made in Pymol
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corresponding region of the 25 serotype O isolates dis-
played 17.2 % (128 of 739 aa) variable residues (Table 2).
As expected, the internally located 1A (15.3 % for the
FMDV A and 4.7 % for FMDV O) remained the most
conserved, with 1D (43.0 % for FMDV A and 29.9 % for
FMDV O) the most variable FMDV capsid protein. The
variability for 1C was 28.4 % for FMDV A and 16.2 % for
FMDV O, compared to 24.3 % for FMDV A and 11.5 %
for FMDV O when looking at 1B (Table 2).
A systematic analysis of the capsid proteins revealed the
variation not to be random but focused in local regions of
hypervariability. The most variable capsid region, 1D,
displayed the most regions of hypervariability. Figure 3A
shows the hypervariable regions of type O at aa positions
34-60, 76-87, 135-147, 152-160, 196-213. At least seven
discrete hypervariable regions (21-63, 80-87, 97-104,
135-146, 150-163, 167-176, 193-207) were identified in 1D
of type A (Fig. 3B).
The conserved N-terminal motif of 1B, DKKTEETTL-
LEDRIL-TTRNGHTTSTTQSSVG, described by Carrillo
et al. [20], was present in the African A and O sequences
(results not shown). Two hypervariable sites, residues
72-85 within the bB-bC loop and 131-141 in the bE-bF
loop, were mapped within 1B of type O (Fig. 3C). 1B of
type A displayed the same two hypervariable regions,
residues 61-92 and 129-139, and a third hypervariable
region, 188-198 (bH-bI loop; Fig. 3D).
Most of the 1C aa substitutions for type O were con-
centrated in one hypervariable region, i.e. 68-80. A second
region with significant variability worth mentioning was
residues 175-181, where three residue positions displayed
high entropy and were located within a surface-exposed
loop of 1C (Fig. 3E). The latter was situated in the b-b
‘knob’ of 1C and included the epitope site 4 for serotype O
[43]. At least three hypervariable regions were identified in
the type A alignment, i.e. residues 58-72, 132-142 and
197-211 (Fig. 3F).
The 1A protein of serotype O was most conserved, with
only four variable residues and hypervariable regions that
were not common for 1A (not shown).
The amino acids that have previously been identified as
critical for FMDV were compared to the complete aa
sequence alignment of the African and non-African A and
O isolates from this study and are summarized in Supple-
mentary data S5, showing that the aa residues important for
FMDV function are conserved.
Investigation of possible heparan sulphate usage for O/
KEN/10/95
Amino acid sequence alignments of all the African FMDV
A and O viruses investigated in this study revealed an Arg
at position 56 of 1C for only one African virus, O/KEN/10/
95 (results not shown). The studies of Sa-Carvalho et al.
Table 4 Comparison of hypervariable regions identified in this study and previously identified neutralizing sites of type A and O FMDV
FMDV Axis Capsid B-sheet structure Hypervariable region indentified in this studya,c Previously identified neutralisation sitesb,c
Type O 59 1D B-C 1034-1060 Site 3: 1043-1048
T-help: 1024-1042
29 1D G-H 1135-1147 Site 1a: 1144-149;1154
1B E-F 2131-2141 Site 2: 2131-2134; 2188
39 1B B-C 2072-2085 Site 2: 2070-2078
1C B-C Site 4: 3056-3058
1D CT 1196-1213 Site 1b: 1206-1208
Type A 59 1D H-I 1167-1176 Site 4: 1169; 1175-1178
29 1D G-H 1135-1146 & 1150-1163 Site 1: 1142-1157;
1138-1144
1B H-I 2188-2198 Site 3: 2196
39 1B Site 3: 2079; 2082-2088
1C B-B 3058-3072 Site 5: 3058-3061
1C B-C 3058-3072 Site 5: 3069-3070
1D CT 1193-1207 Site 2: 1198; 1200-1212
1C E-F 3132-3142 Site 3: 3136-3139
a The hypervariable regions were derived from the alignment of serotype A and O capsid sequences
b The antigenic sites are a summary of those described by Thomas et al. [80]; Baxt et al. [11]; Bolwell et al. [16]; Saiz et al. [72] (type A); Kitson
et al. [43]; Crowther et al. [21]; Barnett et al. [5]; Barnett et al. [6] (type O)
c The amino acid residues have been numbered independently for each FMDV protein. For each residue, the first digit indicates the protein (1D,
1B or 1C), and the last three digits indicate the amino acid position
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[68] and Fry et al. [28] confirmed the importance of the
R56 residue of 1C for HS binding and cell culture adap-
tation. FMDV plaque assays in CHO-K1 cells (Table 3)
confirmed that O/KEN/10/95 was the only virus that was
able to infect and replicate in this cell line. Taking all of the
serotype O capsid-sequence data together, 25 of the 27 O
isolates had a His residue at position 56 of 1C, and they
might therefore require integrins to replicate in cell culture.
Amino acid sequence variation in relation to structure
Vaccines based on A22/Iraq/64, A/ERI/98 and O1Manisa
are recommended for the control of FMD in Africa [33].
We examined the variation within the deduced amino acid
sequences of the capsid proteins of the African O and A
isolates and compared the surface-exposed regions with
those of the three recommended vaccine strains. Regions
with high aa variability in an alignment of the capsid
proteins were mapped onto the X-ray crystallographic
structures of type A (A10/HOL/61; 1QQP) [29] and O
(O1BFS; 1FOD) [53] viruses. Figure 4 shows that the
regions of variability were mostly located on surface-
exposed regions of the virion. Not all of the aa side chains
within a variable region were exposed on the surface.
Closer inspection of each aa position within a region of
hypervariability indicated that positions with high vari-
ability had side chains exposed to the microenvironment of
the virion.
For serotype A viruses, most of the hypervariable
regions outside the 1D bG-bH loop were concentrated
around the 5-fold and 3-fold axes of the virion and the
C-terminus of 1D (Fig. 4) and correlated to a large extent
with residues previously found to be involved in escape
from neutralization by monoclonal antibodies (Table 4).
Furthermore, many of the putative epitopes were probably
discontinuous. For example, there was close proximity of
1B residue 2191 and 1C residues 3068-3071 and
3197-3198 around the 3-fold pore of the virion (Fig. 4).
Similarly the regions of variability for type O correlated
strongly with epitopes previously identified with distribu-
tion around the 5-fold and 3-fold axes of the virion (Fig. 4;
Table 4).
Discussion
The data from the analysis of the complete capsid-coding
region, P1, as well as the individual capsid-coding regions
indicated that very similar tree topologies existed for the
different genomic regions when comparing the African A
and O viruses with those from other regions of the world.
In general, analysis of the entire structural protein-coding
region improved bootstrap values relative to 1D analysis
alone. The longer the capsid-coding region included in the
analysis, the more accurate the relationship conclusion.
This supports the view that sequencing of the entire capsid-
coding region, rather than 1D alone, is desirable in
molecular evolution studies.
Phylogeny based on the NJ trees of the P1, 1B, 1C and
1D sequences resulted in the grouping of viruses according
to serotype. In addition, the A and O virus clusters could be
further divided into separate groupings of the African and
non-African A and O isolates, which were observed for the
P1, 1B, 1C and 1D NJ, ME and MP trees.
The separate groupings of the African and non-African
A viruses support previous findings for type A viruses.
These could be grouped into three major restricted geno-
types, i.e., Euro-South America, Asia and Africa, based on
1D phylogeny (this study only included FMDV A viruses
from Euro-South America and Africa) [44, 46, 57].
Similarly, based on 1D phylogeny, type O viruses were
divided into three groups: those originating from Asia,
Europe-South America and the Far East [44, 69, 73, 74].
The P1 phylogeny therefore supports the three major virus
groups within serotype O. The eastern and western African
O viruses were grouped together with the SEA and ME-SA
lineages, together with the Pan-Asia strain [44, 45, 73],
albeit as lineages restricted to geographic regions (East
Africa-1, 2, 3, 4 and West Africa). Furthermore, the phy-
logeny is indicative of the transboundary spread of FMDV
in Africa among the East African countries, Uganda,
Kenya, Somalia and Tanzania, that are in close proximity
to each other, which is also true for the West African
countries, i.e. Nigeria, Ivory Coast and Senegal. The
groupings also indicated that the East African and West
African viruses fall into separate large groups. Another
well-supported grouping was observed for the P1, 1B and
1C trees (all methodologies) for O/UGA/1/75, O/UGA/6/
76 and O/UGA/17/98, with a maximum of 15.1 % nt and
6.5 % aa substitutions in any pairwise alignment. This
grouping most likely signifies that the 1998 outbreak
strains re-emerged from older strains that have been
maintained in the endemic area since the early 1970s, i.e.
from 1975 to 1998 (23 years).
There was a difference in the groupings for the 1A trees
when compared to the P1 and other capsid-coding gene
regions where three non-African A isolates clustered with
the non-African O viruses (for all phylogenetic methodol-
ogies). The phylogenetic tree representing the region
encoding the L protein differed from that of the structural
proteins where sub-grouping according to serotype was
much less apparent, which was consistent with previous
findings for this region [81, 86].
Interestingly, certain A and O African viruses clustered
together and also did not separate into geographical regions
such as East and West Africa as observed for the structural
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coding regions. For example, bootstrap support of 73 % for
the L-region NJ tree was observed for the grouping of
O/UGA/17/98, O/UGA/1/75, O/UGA/6/76 & A/ETH/7/92,
which was not observed with the 1A, 1B, 1C, 1D and P1
phylogenetic analysis. This suggests that the African
viruses share similarities or are closely related when
comparing the L sequences, irrespective of serotype. Tak-
ing into account the extensive, uncontrolled movement of
animals across the borders and the ease of virus spread and
infection of multiple serotypes in one animal, the role of
recombination events in the genetic diversification of
FMDV cannot be excluded. Although we did not perform a
study on the occurrence of recombination, the similarities
present between FMDV A and O L sequences could be due
to the occurrence of intertypic recombination events [30,
40–42, 86].
Due to the high mutation rates of FMDV, it is likely that
even brief epidemics might result in the generation of
substantial antigenic variability [35]. However, the adap-
tive significance of this variation remains unclear [34]. The
antigenicity of FMDV is attributed to the aa residues that
are exposed on the surface of the capsid [56]. An important
immunogenic determinant, the 1D G-H loop [3], exhibited
a high degree of variation for the A and O isolates included
in this study. Consequently, aa changes in this region are
most likely involved in the appearance of novel antigenic
types. Analyses of antigenic sites of picornaviruses have
been carried out using neutralising monoclonal antibodies
(Mabs) to select and screen Mab-resistant mutants.
Sequence analysis of these mutants resulted in the identi-
fication of five antigenic sites of serotype O virus, i.e., O1
Kaufbeuren [21, 44], and six sites for the FMDV A viruses
[44]. Alignments of the aa sequences of the African A and
O viruses indicated that the regions of variability identified
corresponded to the known antigenic sites, which points to
the fact that the location of antigenic sites are structurally
conserved for the African A and O viruses. In addition to
these sites, other regions of variability were identified for
both the FMDV O and A African isolates from the aa
variability plots. These regions could potentially be anti-
genic determinants, which may be difficult to map by the
classical methodology of MAb-resistant escape mutants.
We have recently shown that an approach combining
sequence variation with structural data and antigenic var-
iation results in the reasonably accurate identification of
novel antigenic determinants on the virion surface [65].
The aligned Lpro aa sequences displayed marked varia-
tion in both the Lab and Lb regions (not shown); however,
despite this variation, the aa residues identified as being
critical for the Lpro function were highly conserved, i.e., the
residues C53, H153 and D168 required for Lpro catalytic
activity, the E81 residue required for Lpro autocatalysis,
and two His residues (H114 and H143) important for
cleavage of the translation initiation factor, eIF4G, [31, 48,
62, 63]. A comparison of the L/P1 cleavage sequence at the
C-terminus of the L protein and N-terminus of the 1A
protein of the FMDV non-African A types revealed a
sequence of R(Q/W)KLK*GAGQ (* indicates cleaved
peptide bond), whereas the African A types included in this
study had the sequence K(R)R(K)LK*GAGQ (results not
shown). Both the FMDV non-African and African O types
revealed a sequence of (K/R)(K/R)L(K/R)*GAGQ (*
indicates cleaved peptide bond) (results not shown). These
observations compared well with the Lpro/1A junction
previously described for serotypes A, O and C [76], where
the residues K(R)R(K)LK(R) at the Lpro C terminus and the
GAGQ at the 1A N terminus were observed. These results
suggest that for all the A and O types included in this study,
the conserved sequence XXLK(R)*GAGQ (where X is
either K or R) is sufficient for L/P1 cleavage by Lpro.
The degree of hydrophobicity/hydrophilicity of the
loops connecting the b chains varied between the African
A and O surface proteins. Hydrophilic b-b loops tend to be
exposed on the protein surface, sometimes protruding from
the protein core, and are candidates for antibody binding
[87]. Overall, the aa sequence variation observed for the
FMDV A and O viruses included in this study showed that
the A viruses exhibited more variation, possibly indicating
that the A viruses evolved rapidly, which supports studies
by Bachrach [2] and Brooksby [19]. Additionally, Tully
and Fares [84] showed that among all of the FMDV sero-
types, serotype A is the most divergent and that adaptive
evolution has occurred in the 3C protease (involved in
RNA replication and processing of the polyprotein) and 2B
(involved in membrane rearrangements), which supports
the hypothesis of selection for faster replication in serotype
A.
Neff et al. [59] showed that a variant of the type O1
virus containing an Arg at residue 56 of 1C required only
HS binding to replicate in CHO-K1 cells but that another
variant with a His residue at this position required integrins
to replicate in cell culture. Interestingly, in this study, it
was shown that O/KEN/10/95 was the only African virus to
have this Arg residue at residue 56 of 1C, and it was indeed
able to replicate in CHO-K1 cells. However this virus has
been passaged three times on IB-RS-2 cells, and it is
possible that the mutation arose during cell culture passage.
Additionally, various aa residues that were previously
identified as important for playing a role in various func-
tions for FMDV were found to be conserved for the A and
O isolates (see ‘‘Results’’).
It is clear from the outbreaks of FMD during the last two
decades that there is a continuing threat to the livestock
industry. The results presented here show distinct geo-
graphical grouping of serotype A and O viruses in Africa,
although common ancestry with the Euro-South American-
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Asian topotypes is clear. The natural diversification of
FMDV occurs during replication in infected animals and
results in the rapid generation of mutants and the ability to
persist and to spread amongst livestock. Thus, continuous
surveillance and an active molecular epidemiology pro-
gram increases our knowledge with regard to FMDV
phylogenetic relationships, virus antigenicity, and the
ability of existing vaccine strains to provide protection
against emerging and re-emerging viruses.
Acknowledgments This work was supported by the SA-UK col-
laboration initiative via the Department of Science and Technology.
The authors would like to express their gratitude to the personnel at
the ARC-OVI (TADP) for their contributions to virus isolation. We
would like to thank Dr. B. Blignaut for assistance with plaque titra-
tions. We also gratefully acknowledge Dr. O. Koekemoer, Dr. M. van
Kleef and Dr. N. Singanallur for critical reading of the manuscript.
Open Access This article is distributed under the terms of the
Creative Commons Attribution License which permits any use, dis-
tribution, and reproduction in any medium, provided the original
author(s) and the source are credited.
References
1. Alexandersen S, Zhang Z, Donaldson AI, Garland AJM (2003)
The pathogenesis and diagnosis of foot-and-mouth disease.
J Comp Path 129:1–36
2. Bachrach HL (1968) Foot-and-mouth disease. Annu Rev
Microbiol 22:201–244
3. Bachrach HL, Morgan DO, McKercher PD, Moore DM, Rob-
ertson BH (1982) Foot-and-mouth disease virus: immunogenicity
and structure of fragments derived from capsid protein VP and of
virus containing cleaved VP. Vet Microbiol 7:85–96
4. Baranowski E, Sevilla N, Verdaguer N, Ruiz-Jarabo CM, Beck E,
Domingo E (1998) Multiple virulence determinants of foot-and-
mouth disease virus in cell culture. J Virol 72:6362–6372
5. Barnett PV, Ouldridge EJ, Rowlands DJ, Brown F, Parry NR
(1989) Neutralization epitopes of type O foot-and-mouth disease
virus. I. Identification and characterization of three functionally
independent, conformational sites. J Gen Virol 70:1483–1491
6. Barnett PV, Samuel AR, Pullen L, Ansell D, Butcher RN,
Parkhouse RME (1998) Monoclonal antibodies, against O00
serotype foot-and-mouth disease virus, from a natural bovine
host, recognize similar antigenic features to those defined by the
mouse. J Gen Virol 79:1687–1697
7. Bastos AD (1998) Detection and characterisation of foot-and-
mouth disease in sub-Saharan Africa. Onderstepoort J Vet Res
65:37–47
8. Bastos AD, Haydon DT, Forsberg R, Knowles NJ, Anderson EC,
Bengis RG, Nel LH, Thomson GR (2001) Genetic heterogeneity
of SAT-1 type foot-and-mouth disease viruses in southern Africa.
Arch Virol 146:1537–1551
9. Bastos AD, Haydon DT, Sangare´ O, Boshoff CI, Edrich JL,
Thomson GR (2003) The implications of virus diversity within
the SAT 2 serotype for control of foot-and-mouth disease in sub-
Saharan Africa. J Gen Virol 84:1595–1606
10. Bastos AD, Anderson EC, Bengis RG, Keet DF, Winterbach HK,
Thomson GR (2003) Molecular epidemiology of SAT3-type foot-
and-mouth disease. Virus Genes 27:283–290
11. Baxt B, VakhariaV, Moore DM, Franke AJ, Morgan DO (1989)
Analysis of neutralising antigenic sites on the surface of type A12
foot-and-mouth disease virus. J Virol 63:2143–2151
12. Beck E, Strohmaier K (1987) Subtyping of European foot-and-
mouth disease virus strains by nucleotide sequence determina-
tion. J Virol 61:1621–1629
13. Belsham GJ (1993) Distinctive features of foot-and-mouth dis-
ease virus, a member of the picornavirus family; aspects of virus
protein synthesis, protein processing and structure. Biophys
Molec Biol 60:241–260
14. Berinstein A, Rovainen M, Hovi T, Mason PW, Baxt B (1995)
Antibodies to the vitronectin receptor (integrin avb3) inhibit
binding and the infection of foot-and-mouth disease virus to
cultured cells. J Virol 69:2664–2666
15. Birtley JR, Knox SR, Jaulent AM, Brick P, Leatherbarrow RJ,
Curry S (2005) Crystal structure of foot-and-mouth disease virus
3C protease: New insights into catalytic mechanism and cleavage
specificity. J Biol Chem 280:11520–11527
16. Bolwell C, Clarke BE, Parry NR, Oulridge EJ, Brown F, Row-
lands DJ (1989) Epitope mapping of foot-and-mouth disease
virus with neutralizing monoclonal antibodies. J Gen Virol
70:59–68
17. Boom R, Sol CJ, Salimans MMM, Jansen CL, Wertheim-van
Dillen PME, Van Der Noordaa J (1990) Rapid and simple method
for purification of nucleic acids. J Clin Microbiol 28:495–503
18. Bronsvoort BM, Sørensen KJ, Anderson J, Corteyn A, Tanya VN,
Kitching RP, Morgan KL (2004) Comparison of two 3ABC
enzyme-linked immunosorbent assays for diagnosis of multiple-
serotype foot-and-mouth disease in a cattle population in an area
of endemicity. J Clin Microbiol 42:2108–2114
19. Brooksby JB (1982) Portraits of viruses: foot-and-mouth disease
virus. Intervirology 18:1–23
20. Carrillo C, Tulman ER, Delhon G, Lu Z, Carreno A, Vagnozzi A,
Kutish GF, Rock DL (2005) Comparative genomics of Foot and
mouth disease virus. J Virol 79:6487–6504
21. Crowther JR, Farias S, Carpenter WC, Samuel AR (1993) Iden-
tification of a fifth neutralisable site on type O foot-and-mouth
disease virus following characterization of single and quintuple
monoclonal antibody escape mutants. J Gen Virol 74:1547–1553
22. Di Nardo A, Knowles NJ, Paton DJ (2011) Combining livestock
trade patterns with phylogenetics to help understand the spread of
foot-and-mouth disease in sub-Saharan Africa, the Middle East
and Southeast Asia. Rev Sci Tech Off Int Epiz 30(1):63–85
23. Domingo E, Martinez-Salas E, Sobrino F, de la Torre CJ, Portela
A, Ortin J, Lopez-Galindez C, Perez-Brena P, Villanueva N,
Najera R, VandePol S, Steinhauer D, DePolo N, Holland J (1985)
The quasispecies (extremely heterogeneous) nature of viral RNA
genome populations: biological relevance—a review. Gene
40:1–8
24. Domingo E, Baranowski E, Escarmis C, Sobrino F (2002) Foot-
and-mouth disease virus. Comp Imm Micro Infect Dis
25:297–308
25. Duque H, Baxt B (2003) Foot-and-mouth disease virus receptors:
Comparison of bovine av integrin utilization by type A & O
viruses. J Virol 77:2500–2511
26. European Commission (2004) Report of the session of the
research group of the standing technical Committee of the
European commission for the control of foot-and-mouth disease
(EUFMD) held at Chania, Crete (Greece)
27. Forss S, Strebel K, Beck E, Schaller H (1984) Nucleotide
sequence and genome organization of foot-and-mouth disease
virus. Nucleic Acids Res 12:6587–6601
28. Fry E, Lea SM, Jackson T, Newman JWI, Ellard FM, Blakemore
WE, Ghazaleh RA, Samuel A, King AMQ, Stuart DI (1999) The
structure and function of a foot and mouth disease virus-oligo-
saccharide receptor complex. EMBO J 18:543–554
Genetic heterogeneity of FMDV African types A and O 959
123
29. Fry EE, Stuart DI, Rowlands DJ (2005) The structure of foot-and-
mouth disease virus. Foot-and-mouth Disease Virus. Springer,
Berlin, pp 71–102
30. Giraudo AT, Sagedahl A, Bergmann IE, La Torre JL, Scodeller
EA (1987) Isolation and characterization of recombinants
between attenuated and virulent aphthovirus strains. J Virol
61:419–425
31. Gorbalenya AE, Koonin EV, Lai MM (1991) Putative papain-
related thiol proteases of positive strand RNA viruses. Identifi-
cation of rubi- and aphthovirus proteases and delineation of a
novel conserved domain associated with proteases of rubi-, alpha-
and coronaviruses. FEBS Lett 288:201–205
32. Hall TA (1999) BioEdit: a user-friendly biological sequence
alignment editor and analysis program for Windows 95/98/NT.
Nucl Acids Sym Ser 41:95–98
33. Hammond J (2011) OIE/FAO FMD reference laboratory network
annual report
34. Haydon D, Lea S, Fry L, Knowles N, Samuel AR, Stuart D,
Woolhouse EJ (1998) Characterising sequence variation in the
VP1 capsid proteins of foot-and-mouth disease virus (serotype O)
with the respect to virion structure. J Mol Evol 46:465–475
35. Haydon DT, Bastos AD, Knowles NJ, Samuel AR (2001) Evi-
dence for positive selection in foot-and-mouth disease virus
capsid genes from field isolates. Genetics 157:7–15
36. Jackson T, Ellard FM, Ghazaleh RB, Brookes SM, Blakemore
WE, Corteyn AH, Stuart DI, Newman JWI, King AM (1996)
Efficient infection of cells in culture by type O foot-and-mouth
disease virus requires binding to cell surface heparan sulfate.
J Virol 70:5282–5287
37. Jackson T, Sheppard D, Denyer M, Blakemore W, King AMQ
(2000) The epithelial integrin avb6 is a receptor for foot-and-
mouth disease virus. J Virol 74:4949–4956
38. Jackson T, Mould AP, Sheppard D, King AMQ (2002) Integrin
avb1 is a receptor for foot-and-mouth disease virus. J Virol
76:935–941
39. Jackson T, Clark S, Berryman S, Burman A, Cambier S, Mu D,
Nishimura S, King AMQ (2004) Integrin avb8 functions as a
receptor of foot-and-mouth disease virus: Role of the b-chain
cytodomain in integrin-mediated infection. J Virol 78:4533–4540
40. Jackson AL, O’Neill H, Maree FF, Blignaut B, Carrillo C,
Rodriguez L, Haydon DT (2007) Mosaic structure of foot-and-
mouth disease virus genomes. J Gen Virol 88:487–492
41. King AMQ, McCahon D, Slade WR, Newman JWI (1982)
Recombination in RNA. Cell 29:921–928
42. King AMQ, McCahon D, Saunders K, Newman JWI, Slade WR
(1985) Multiple sites of recombination within the RNA genome
of foot-and-mouth disease virus. Virus Res 3:373–384
43. Kitson JDA, McCahon D, Belsham GJ (1990) Sequence analysis
of monoclonal antibody resistant mutants of type O foot and
mouth disease virus: evidence for the involvement of the three
surface exposed capsid proteins in four antigenic sites. Virology
179:26–34
44. Knowles NJ, Samuel AR (2003) Molecular epidemiology of foot-
and-mouth disease virus. Virus Res 91:65–80
45. Knowles NJ, Samuel AR, Davies PR, Midgley RJ, Valarcher JF
(2005) Pandemic strain of foot-and-mouth disease virus serotype
O. Emerg Infect Dis 11:1887–1893
46. Knowles NJ, Wadsworth J, Reid SM, Swabey KG, El-Kholy AA,
El-Rahman AOA, Soliman HM, Ebert K, Ferris NP, Hutchings
GH, Statham RJ, King DP, Paton DJ (2007) Foot-and-mouth
disease virus serotype A in Egypt. Emerg Infect Dis
13:1593–1596
47. Knowles NJ, Nazem Shirazi MH, Wadsworth J, Swabey KG,
Stirling JM, Statham RJ, Li Y, Hutchings GH, Ferris NP, Parlak
U, Ozyo¨ru¨k F, Sumption KJ, King DP, Paton DJ (2009) Recent
spread of a new strain (A-Iran-05) of foot-and-mouth disease
virus type A in the Middle East. Transbound Emerg Dis
56:157–169
48. Kronovetr J, Skern T (2002) Foot-and-mouth disease virus leader
proteinase: a papain-like enzyme requiring and acidic environ-
ment in the active site. FEBS Lett 528:58–62
49. Ku¨hn R, Luz N, Beck E (1990) Functional analysis of the internal
translation initiation site of foot-and-mouth disease virus. J Virol
64:4625–4631
50. Kumar S, Tamura K, Nei M (1993) MEGA: Molecular evolu-
tionary genetics analysis version 3.0. Pennsylvania State Uni-
versity, USA
51. Kyte J, Doolittle RF (1982) A simple method for displaying the
hydropathic character of a protein. J Mol Biol 157:105–132
52. Li D, Liu ZX, Bao HF, Lu ZJ, Guo JH, Cao YM, Li PH, Bai XW,
Chen YL, Xie BX, Cai XP, Xie QG (2007) The complete genome
sequence of foot-and-mouth disease virus O/Akesu/58 strain and
its some molecular characteristics. Arch Virol 152:2079–2085
53. Logan D, Abu-Ghazaleh R, Blakemore W, Curry S, Jackson T,
King A, Lea S, Lewis R, Newman J, Parry N, Rowlands D, Stuart
D, Fry E (1993) Structure of a major immunogenic site on foot-
and-mouth disease virus. Nature 362:566–568
54. Maree FF, Blignaut B, de Beer TA, Visser N, Rieder EA (2010)
Mapping of amino acid residues responsible for adhesion of cell
culture-adapted foot-and-mouth disease SAT type viruses. Virus
Res 153:82–91
55. Mason PW, Pacheco JM, Zhao QZ, Knowles NJ (2003) Com-
parisons of the complete genomes of Asian, African and Euro-
pean isolates of a recent foot-and-mouth disease virus type O
pandemic strain (PanAsia). J Gen Virol 84:1583–1593
56. Mateu MG, Camarero JA, Giralt E, Andreu D, Domingo E (1995)
Direct evaluation of the immunodominance of a major antigenic
site of foot-and-mouth disease virus in a natural host. Virology
206:298–306
57. Nayak B, Pattnaik B, Tosh C, Sanyal A, Hemadri D, Patil SS,
Venkataramanan R (2001) Genetic and antigenic analysis of type
A foot-and-mouth disease viruses isolated in India during
1987-1996. Acta Virol 45:13–21
58. Nayak A, Goodfellow IG, Woolaway KE, Birtley J, Curry S,
Belsham GJ (2006) Role of RNA structure and RNA binding
activity of foot-and-mouth disease virus 3C Protein in VPg ur-
idylylation and virus replication. J Virol 80:9865–9875
59. Neff S, Sa-Carvalho D, Rieder E, Mason PW, Blystone SD,
Brown EJ, Baxt B (1998) Foot-and-mouth disease virus virulent
for cattle utilizes the integrin avb3 as its receptor. J Virol
72:3587–3594
60. Neff S, Mason PW, Baxt B (2000) High efficiency utilization of
the bovine integrin avb3 as a receptor for foot and mouth disease
virus is dependant on the bovine b3 subunit. J Virol
74:7298–7306
61. Nobiron I, Remond M, Kaiser C, Lebreton F, Zientara S, Delmas
B (2005) The nucleotide sequence of foot-and-mouth disease
virus O/FRA/1/2001 and comparison with its British parental
strain O/UKG/35/2001. Virus Res 108:225–229
62. Piccone ME, Rieder E, Mason PW, Grubman MJ (1995) The
foot-and-mouth disease virus leader proteinase gene is not
required for viral replication. J Virol 69:5376–5382
63. Piccone ME, Zellner M, Kumosinski TF, Mason PW, Grubman MJ
(1995) Identification of the active-site residues of the L-proteinase
of foot-and-mouth disease virus. J Virol 69:4950–4956
64. Pringle CR (1965) Evidence of genetic recombination in foot-
and-mouth disease virus. Virology 25:48–54
65. Reeve R, Blignaut B, Esterhuysen JJ, Opperman P, Matthews L,
Fry EE, de Beer TA, Theron J, Rieder E, Vosloo W, O’Neill HG,
Haydon DT, Maree FF (2010) Sequence-based prediction for
vaccine strain selection and identification of antigenic variability
in foot-and-mouth disease virus. PLoS Comput Biol 6:e1001027
960 M. Chitray et al.
123
66. Rieder E, Bunch T, Brown F, Mason PW (1993) Genetically
engineered foot-and-mouth disease viruses with poly(C) tracts of
two nucleotides are virulent in mice. J Virol 67:5139–5145
67. Rueckert RR (1996) Picornaviridae: the viruses and their repli-
cation. In: Fields BN, Knipe BN, Howley PM (eds) Virology.
Lippincott-Raven Publishers, Philadelphia, pp 609–654
68. Sa-Carvalho D, Reider E, Baxt B, Rodarte R, Tanuri A, Mason
PW (1997) Tissue culture adaptation of foot-and-mouth disease
virus selects viruses that bind to heparin and are attenuated in
cattle. J Virol 71:5115–5123
69. Sahle M, Venter EH, Dwarka RM, Vosloo W (2004) Molecular
epidemiology of serotype O foot-and-mouth disease virus iso-
lated from cattle in Ethiopia between 1979–2001. Onderstepoort J
Vet Res 71:129–138
70. Sahle M, Dwarka RM, Venter EH, Vosloo W (2007) Comparison
of SAT-1 foot-and-mouth disease virus isolates obtained from
East Africa between 1971 and 2000 with viruses from the rest of
sub-Saharan Africa. Arch Virol 152:797–804
71. Sahle M, Dwarka RM, Venter EH, Vosloo W (2007) Study of the
genetic heterogeneity of SAT-2 foot-and-mouth disease virus in
sub-Saharan Africa with specific focus on East Africa. Onder-
stepoort J Vet Res 74:289–299
72. Saiz JC, Gonzalez MJ, Borca MV, Sobrino F, Moore DM (1991)
Identification of neutralising antigenic sites on VP1 and VP2 of
type A5 foot-and-mouth disease virus, defined by neutralisa-
tionresistant variants. J Virol 65:2518–2524
73. Samuel AR, Knowles NJ (2001) Foot-and-mouth disease type O
viruses exhibit genetically and geographically distinct evolu-
tionary lineages (topotypes). J Gen Virol 82:609–621
74. Sangare O, Bastos AD, Marquardt O, Venter EH, Vosloo W,
Thomson GR (2001) Molecular epidemiology of serotype O foot-
and-mouth disease virus with emphasis on West and South
Africa. Virus Genes 22:345–351
75. Sangare O, Bastos ADS, Venter EH, Vosloo W (2003) Retro-
spective genetic analysis of SAT-1 type foot-and-mouth disease
outbreaks in West Africa (1975–1981). Vet Microbiol
93:279–289
76. Seipelt J, Guarne A, Bergmann E, James M, Sommergruber W,
Fita I, Skern T (1999) The structures of picornaviral proteinases.
Virus Res 62:159–168
77. Sutmoller P, Barteling SS, Olascoaga RC, Sumption KJ (2003)
Control and eradication of foot-and-mouth disease. Virus Res
91:101–144
78. Sweeney TR, Roque-Rosell N, Birtley JR, Leatherbarrow RJ,
Curry S (2007) Structural and mutagenic analysis of foot-and-
mouth disease virus 3C protease reveals the role of the b-Ribbon
in proteolysis. J Virol 81:115–124
79. Swofford DL (1998) PAUP: phylogenetic analysis using parsi-
mony (and other methods). Sinauer Associates, Sunderland
80. Thomas AA, Woortmeijer RJ, Puijk W, Barteling SJ (1988)
Antigenic sites on foot-and-mouth disease virus type A10. J Virol
62:2782–2789
81. Tosh C, Mittal M, Sanyal A, Hemadri D, Bandyopadhyay SK
(2004) Molecular phylogeny of leader proteinase gene of type A of
foot-and-mouth disease virus from India. Arch Virol 149:523–536
82. Thomson GR (1994) Foot-and-mouth disease. In: Coetzer JAW,
Thomson GR, Tustin RC, Kriek NPJ (eds) Infectious diseases of
livestock with special reference to Southern Africa. Oxford
University Press, Cape Town, pp 825–852
83. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins
DG (1997) The ClustalX windows interface: flexible strategies
for multiple sequence alignment aided by quality analysis tools.
Nuc Acids Res 24:4876–4882
84. Tully DC, Fares MA (2009) Shifts in the Selection-Drift Balance
Drive the Evolution and Epidemiology of Foot-and-Mouth Dis-
ease Virus. J Virol 83(2):781–790
85. Usherwood EJ, Johnston ICD, Lovelidge LJ, Tonks P, Nash AA
(1995) Lymphocyte recognition elements on the VP1 protein of
Theiler’s virus. Immunology 85:190–197
86. Van Rensburg H, Haydon D, Joubert F, Bastos A, Heath L, Nel L
(2002) Genetic heterogeneity in the foot-and-mouth disease virus
Leader and 3C proteinase. Gene 289:19–29
87. Verdaguer N, Sevilla N, Valero ML, Stuart D, Brocchi E, Andreu
D, Giralt E, Domingo E, Mateu MG, Fita I (1998) A similar
pattern of interaction for different antibodies with a major anti-
genic site of foot-and-mouth disease virus: implications for in-
tratypic antigenic variation. J Virol 72:739–748
88. Vosloo W, Bastos ADS, Sangare O, Hargreaves SK, Thomson GR
(2002) Review of the status and control of foot and mouth disease in
sub-Saharan Africa. Rev sci tech Off Int Epiz 21:437–449
89. Zhang X, Liu Z, Zhao Q, Chang H, Xie Q (2004) Sequencing and
analysis for the full-length genome RNA of foot-and-mouth
disease virus China/99. Sci China C Life Sci 47:74–81
Genetic heterogeneity of FMDV African types A and O 961
123
